Good evening :)
Abbott India Ltd

Abbott India Ltd

ABBOTINDIA Share Price

NSE
26,855.003.17% (-880.00)
High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP

With a market cap of ₹57,065 cr, stock is ranked 182

Stock is 1.72x as volatile as Nifty

ABBOTINDIA Stock Scorecard

Performance

Low

Hasn't fared well - amongst the low performers

Valuation

High

Seems to be overvalued vs the market average

Growth

Low

Lagging behind the market in financials growth

Profitability

High

Showing good signs of profitability & efficiency

Entry point

Good

The stock is underpriced and is not in the overbought zone

Red flags

Low

No red flag found

How to use scorecard? Learn more

With a market cap of ₹57,065 cr, stock is ranked 182

Stock is 1.72x as volatile as Nifty

ABBOTINDIA Performance & Key Metrics

ABBOTINDIA Performance & Key Metrics

No LabelNo LabelPB RatioPB RatioDividend YieldDiv. Yield
37.9713.921.71%
Sector PESector PESector PBSector PBSector Div YldSctr Div Yld
41.416.310.47%

ABBOTINDIA Analyst Ratings & Forecast

Detailed Forecast Detailed Forecast 
75%
Analysts have suggested that investors can buy this stock

from 8 analysts

Price Upside

Earnings Growth

Rev. Growth

See Detailed Forecast

ABBOTINDIA Company Profile

Abbott India is a healthcare company engaged in pharmaceuticals business. The Company has a portfolio of offerings in diagnostics, medical devices, nutritionals and branded generic pharmaceuticals.

ABBOTINDIA Similar Stocks (Peers)

Compare with peers Compare with peers 

ABBOTINDIA Similar Stocks (Peers)

Compare with peers Compare with peers 
PE Ratio
38.55
38.55
1Y Return
5.85%
5.85%
Buy Reco %
93.75
93.75
PE Ratio
71.83
71.83
1Y Return
39.53%
39.53%
Buy Reco %
80.77
80.77
PE Ratio
29.53
29.53
1Y Return
5.14%
5.14%
Buy Reco %
62.86
62.86
PE Ratio
26.18
26.18
1Y Return
4.43%
4.43%
Buy Reco %
51.52
51.52
PE Ratio
21.68
21.68
1Y Return
16.54%
16.54%
Buy Reco %
53.57
53.57
Compare with Peers

ABBOTINDIA Forecast

ABBOTINDIA Forecasts

Price

Revenue

Earnings

ABBOTINDIA

ABBOTINDIA

Income

Balance Sheet

Cash Flow

ABBOTINDIA Income Statement

ABBOTINDIA Income Statement

Loading...

Quarterdec 2023mar 2024jun 2024sep 2024dec 2024mar 2025jun 2025sep 2025dec 2025mar 2026
Total Revenue1,492.751,519.781,624.941,693.151,686.031,680.611,811.191,827.101,793.801,785.10
Operating & Other expensessubtract1,049.451,109.101,166.601,193.711,178.191,176.051,292.761,254.981,260.571,228.66
Depreciation/Amortizationsubtract17.9718.1918.3717.5117.9917.9319.4818.6418.7719.07
Interest & Other Itemssubtract3.172.812.752.502.263.925.827.555.486.14
Taxes & Other Itemssubtract111.18102.62109.21120.82126.81115.67127.27130.66133.02136.30
EPS146.34135.09154.36168.76169.78172.72172.17195.42176.92185.85

ABBOTINDIA Company Updates

Annual Report and Investor Presentation updates mentioned here are as reported by the company to the exchange
FY 2025FY 2025

Annual report

PDF
FY 2024FY 2024

Annual report

PDF
FY 2023FY 2023

Annual report

PDF
FY 2022FY 2022

Annual report

PDF
FY 2021FY 2021

Annual report

PDF
FY 2020FY 2020

Annual report

PDF
FY 2019FY 2019

Annual report

PDF
FY 2018FY 2018

Annual report

PDF
FY 2017FY 2017

Annual report

PDF
FY 2016FY 2016

Annual report

PDF
 

ABBOTINDIA Stock Peers

ABBOTINDIA Past Performance & Peer Comparison

ABBOTINDIA Past Performance & Peer Comparison

Comparing 3 stocks from 
Health CarePharmaceuticals

Loading...

StockPE RatioPE RatioPB RatioPB RatioDiv. YieldDividend Yield
Abbott India Ltd37.9713.921.71%
Sun Pharmaceutical Industries Ltd38.556.100.87%
Torrent Pharmaceuticals Ltd71.8320.23
Cipla Ltd29.533.660.92%

ABBOTINDIA Stock Price Comparison

Compare ABBOTINDIA with any stock or ETF
Compare ABBOTINDIA with any stock or ETF
ABBOTINDIA
Loading...

ABBOTINDIA Holdings

ABBOTINDIA Shareholdings

ABBOTINDIA Promoter Holdings Trend

ABBOTINDIA Promoter Holdings Trend

Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

ABBOTINDIA Institutional Holdings Trend

ABBOTINDIA Institutional Holdings Trend

Total Retail Holding
Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.

In last 3 months, retail holding in the company has almost stayed constant

Foreign Institutional Holding
Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock

In last 3 months, foreign institutional holding of the company has almost stayed constant

Tickertape Separator

ABBOTINDIA Shareholding Pattern

ABBOTINDIA Shareholding Pattern

Retail and OthersForeign InstitutionsOther Domestic InstitutionsMutual FundsTotal Promoter Holding74.99%7.68%1.25%0.26%15.81%

Jun 2025

Sep 2025

Dec 2025

Mar 2026

ABBOTINDIA Shareholding History

ABBOTINDIA Shareholding History

Dec '24MarJunSepDec '25Mar0.16%0.16%0.16%0.16%0.18%0.26%

Mutual Funds Invested in ABBOTINDIA

Mutual Funds Invested in ABBOTINDIA

No mutual funds holding trends are available

Top 5 Mutual Funds holding Abbott India Ltd




Funds (Top 5)Market-cap heldWeight3M holding changePortfolio rank
(3M change)
1.3293%2.04%0.16%13/93 (0)
0.7028%1.28%-0.07%14/103 (-1)
0.5981%1.43%-0.14%20/106 (-4)

Compare 3-month MF holding change on Screener

ABBOTINDIA Insider Trades & Bulk Stock Deals

ABBOTINDIA Insider Trades & Bulk Stock Deals

Hmm, looks like there hasn't been any net deal activity in the last 6 months

smallcases containing ABBOTINDIA stock

smallcases containing ABBOTINDIA stock

Looks like this stock is not in any smallcase yet.

ABBOTINDIA Events

ABBOTINDIA Events

ABBOTINDIA Dividend Trend

No Dividend Cuts
Dividends are the portion of earnings that a company distributes to all its shareholders every year

ABBOTINDIA has increased or maintained dividend levels over the last 5 years

Dividend Yield
Dividend return is one of the most important things to be considered while investing for long term. It is the additional return on top of what investors earn through price appreciation

Current dividend yield is 1.71%. An investment of ₹1,000 in the stock is expected to generate dividend of ₹17.13 every year

Dividends

Corp. Actions

Announcements

Legal Orders

ABBOTINDIA Dividend Trend

No Dividend Cuts
Dividends are the portion of earnings that a company distributes to all its shareholders every year

ABBOTINDIA has increased or maintained dividend levels over the last 5 years

Dividend Yield
Dividend return is one of the most important things to be considered while investing for long term. It is the additional return on top of what investors earn through price appreciation

Current dividend yield is 1.71%. An investment of ₹1,000 in the stock is expected to generate dividend of ₹17.13 every year

ABBOTINDIA Upcoming Dividends

ABBOTINDIA Upcoming Dividends

No upcoming dividends are available

ABBOTINDIA Past Dividends

ABBOTINDIA Past Dividends

Cash Dividend

Ex DateEx DateJul 25, 2025

Final
Final | Div/Share: ₹475.00

Dividend/Share

475.00

Ex DateEx Date

Jul 25, 2025

Cash Dividend

Ex DateEx DateJul 19, 2024

Final
Final | Div/Share: ₹410.00

Dividend/Share

410.00

Ex DateEx Date

Jul 19, 2024

Cash Dividend

Ex DateEx DateJul 21, 2023

Final
Final | Div/Share: ₹180.00

Dividend/Share

180.00

Ex DateEx Date

Jul 21, 2023

Cash Dividend

Ex DateEx DateJul 21, 2023

Special
Special | Div/Share: ₹145.00

Dividend/Share

145.00

Ex DateEx Date

Jul 21, 2023

Cash Dividend

Ex DateEx DateAug 2, 2022

Special
Special | Div/Share: ₹130.00

Dividend/Share

130.00

Ex DateEx Date

Aug 2, 2022

ABBOTINDIA Stock News & Opinions

ABBOTINDIA Stock News & Opinions

Spotlight
Spotlight
Abbott India clocks PAT of Rs 394.93 crore in March'26 quarter

Total operating expenditure for the period under review was Rs 1,228.66 crore, up 4.5% YoY. Profit before tax in Q4 FY26 stood at Rs 531.23 crore, up by 10.1% from Rs 482.71 crore in Q4 FY25. For FY26, the company has recorded net profit and revenue from operations of Rs 1552.02 crore (up 9.7% YoY) and Rs 6,929.05 crore (up 8.1% YoY), respectively. Abbott India is one of the leading multinational pharmaceutical companies in India and sells its products through independent distributors primarily within India. The scrip fell 1.99% to currently trade at Rs 27224.40 on the BSE. Powered by Capital Market - Live

2 weeks agoCapital Market - Live
Corporate
Corporate
Abbott India to convene AGM

Abbott India announced that the 82th Annual General Meeting(AGM) of the company will be held on 13 August 2026.

2 weeks agoCapital Market - Live
Corporate
Corporate
Board of Abbott India recommends final dividend

Abbott India announced that the Board of Directors of the Company at its meeting held on 11 May 2026, inter alia, have recommended the final dividend of Rs 525 per equity Share (i.e. 5250%) , subject to the approval of the shareholders.

2 weeks agoCapital Market - Live
Corporate
Corporate
Board of Abbott India recommends special dividend

Abbott India announced that the Board of Directors of the Company at its meeting held on 11 May 2026, inter alia, have recommended the special dividend of Rs 131 per equity Share (i.e. 1310%) , subject to the approval of the shareholders.

2 weeks agoCapital Market - Live
Earnings
Earnings
Abbott India standalone net profit rises 7.60% in the March 2026 quarter

Net profit of Abbott India rose 7.60% to Rs 394.93 crore in the quarter ended March 2026 as against Rs 367.04 crore during the previous quarter ended March 2025. Sales rose 6.54% to Rs 1709.51 crore in the quarter ended March 2026 as against Rs 1604.59 crore during the previous quarter ended March 2025. For the full year,net profit rose 9.73% to Rs 1552.02 crore in the year ended March 2026 as against Rs 1414.44 crore during the previous year ended March 2025. Sales rose 8.11% to Rs 6929.05 crore in the year ended March 2026 as against Rs 6409.15 crore during the previous year ended March 2025. ParticularsQuarter EndedYear EndedMar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var. Sales1709.511604.59 7 6929.056409.15 8 OPM %28.1326.71 -27.3126.44 - PBDT550.30500.64 10 2155.231958.75 10 PBT531.23482.71 10 2079.271886.95 10 NP394.93367.04 8 1552.021414.44 10 Powered by Capital Market - Live

2 weeks agoCapital Market - Live
Corporate
Corporate
Abbott India to discuss results

Abbott India will hold a meeting of the Board of Directors of the Company on 11 May 2026.

4 weeks agoCapital Market - Live
Earnings
Earnings
Abbott India standalone net profit rises 4.21% in the December 2025 quarter

Net profit of Abbott India rose 4.21% to Rs 375.96 crore in the quarter ended December 2025 as against Rs 360.78 crore during the previous quarter ended December 2024. Sales rose 6.80% to Rs 1724.04 crore in the quarter ended December 2025 as against Rs 1614.28 crore during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var. Sales1724.041614.28 7 OPM %26.8827.01 - PBDT527.75505.58 4 PBT508.98487.59 4 NP375.96360.78 4 Powered by Capital Market - Live

3 months agoCapital Market - Live
Spotlight
Spotlight
Abbott India Q3 PAT jumps 4% YoY to Rs 376 cr

Profit before tax (PBT) stood at Rs 508.98 crore in Q3 FY26, up 4.38% year on year (YoY). Total expenses increased 7.20% to Rs 1,284.82 crore in Q3 FY26 as against Rs 1,198.44 crore posted in same quarter last year. The cost of materials consumed stood at Rs 147.31 crore (up 26.88% YoY), employee benefit expense was at Rs 196.07 crore (up 45.58% YoY) and finance cost was at Rs 5.48 crore (up 142.47% YoY) during the period under review. Abbott India is one of the leading multinational pharmaceutical companies in India and sells its products through independent distributors primarily within India. Shares of Abbott India fell 1.06% to currently trade at Rs 26,609.95 on the BSE. Powered by Capital Market - Live

3 months agoCapital Market - Live
Corporate
Corporate
Abbott India to announce Quarterly Result

Abbott India will hold a meeting of the Board of Directors of the Company on 12 February 2026.Powered by Capital Market - Live

3 months agoCapital Market - Live
Spotlight
Spotlight
Volumes soar at Abbott India Ltd counter

HDFC Life Insurance Company Ltd, NTPC Ltd, V-Guard Industries Ltd, Triveni Turbine Ltd are among the other stocks to see a surge in volumes on BSE today, 22 January 2026.Abbott India Ltd clocked volume of 4115 shares by 10:45 IST on BSE, a 12.24 times surge over two-week average daily volume of 336 shares. The stock gained 0.41% to Rs.27,717.00. Volumes stood at 499 shares in the last session.HDFC Life Insurance Company Ltd saw volume of 6.65 lakh shares by 10:45 IST on BSE, a 8.56 fold spurt over two-week average daily volume of 77681 shares. The stock increased 0.18% to Rs.725.00. Volumes stood at 67359 shares in the last session.NTPC Ltd saw volume of 31.03 lakh shares by 10:45 IST on BSE, a 6.39 fold spurt over two-week average daily volume of 4.86 lakh shares. The stock increased 0.47% to Rs.340.25. Volumes stood at 2.99 lakh shares in the last session.V-Guard Industries Ltd registered volume of 1.57 lakh shares by 10:45 IST on BSE, a 4.84 fold spurt over two-week average daily volume of 32516 shares. The stock slipped 0.61% to Rs.307.20. Volumes stood at 15558 shares in the last session.Triveni Turbine Ltd recorded volume of 10.57 lakh shares by 10:45 IST on BSE, a 4.48 times surge over two-week average daily volume of 2.36 lakh shares. The stock gained 0.44% to Rs.471.40. Volumes stood at 3.32 lakh shares in the last session.Powered by Capital Market - Live

4 months agoCapital Market - Live

Frequently asked questions

Frequently asked questions

  1. What is the share price of Abbott India Ltd (ABBOTINDIA) today?

    The share price of ABBOTINDIA as on 29th May 2026 is ₹26855. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.

  2. What is the return on Abbott India Ltd (ABBOTINDIA) share?

    The past returns of Abbott India Ltd (ABBOTINDIA) share are
    • Past 1 week: -3.33%
    • Past 1 month: 5.03%
    • Past 3 months: 1.23%
    • Past 6 months: -9.91%
    • Past 1 year: -11.52%
    • Past 3 years: 22.66%
    • Past 5 years: 67.54%

  3. What are the peers or stocks similar to Abbott India Ltd (ABBOTINDIA)?
  4. What is the dividend yield % of Abbott India Ltd (ABBOTINDIA) share?

    The current dividend yield of Abbott India Ltd (ABBOTINDIA) is 1.77.

  5. What is the market cap of Abbott India Ltd (ABBOTINDIA) share?

    Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Abbott India Ltd (ABBOTINDIA) is ₹57065.00 Cr as of 29th May 2026.

  6. What is the 52 week high and low of Abbott India Ltd (ABBOTINDIA) share?

    The 52-week high of Abbott India Ltd (ABBOTINDIA) is ₹37000 and the 52-week low is ₹25150.

  7. What is the PE and PB ratio of Abbott India Ltd (ABBOTINDIA) stock?

    The P/E (price-to-earnings) ratio of Abbott India Ltd (ABBOTINDIA) is 36.77. The P/B (price-to-book) ratio is 13.48.

  8. Which sector does Abbott India Ltd (ABBOTINDIA) belong to?

    Abbott India Ltd (ABBOTINDIA) belongs to the Health Care sector & Pharmaceuticals sub-sector.

  9. How to buy Abbott India Ltd (ABBOTINDIA) shares?

    You can directly buy Abbott India Ltd (ABBOTINDIA) shares on Tickertape. Simply sign up, connect your demat account and place your order.